MedTrace Logo

The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects

NCT01876316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-06-12

No results posted yet for this study

Summary

The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects

Conditions

  • Healthy

Interventions

DRUG

Moxifloxacin

single oral administration of 400mg of moxifloxacin

DRUG

Placebo

single oral administration of 400mg of placebo

Sponsors & Collaborators

  • Inje University

    lead OTHER

Principal Investigators

  • Jae-Gook Shin, MD, PhD · Inje University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-09-30
Completion
2013-01-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01876316 on ClinicalTrials.gov